METHODS: A 47-year-old woman went to the hospital because of anemia.
METHODS: The patient was diagnosed with uterine leiomyoma.
METHODS: The patient refused the suggestion of surgery, she was continuously treated with an ultra-low-dose (12.5 mg per 5 days) of mifepristone monotherapy for 4 years.
RESULTS: The uterine leiomyoma was stable, anemia and other symptoms disappeared, and the menstrual cycle, liver and kidney function, and tumor markers were normal.
CONCLUSIONS: Judging from our case, long-term, ultra-low-dose mifepristone for uterine fibroids treatment was safe and more effective than conventional therapy.
方法:一名47岁的妇女因贫血而去医院。
方法:患者诊断为子宫平滑肌瘤。
方法:患者拒绝手术建议,患者连续接受超低剂量(12.5mg/5日)米非司酮单药治疗4年.
结果:子宫平滑肌瘤稳定,贫血等症状消失,和月经周期,肝肾功能,肿瘤标志物正常.
结论:从我们的案例来看,长期的,超小剂量米非司酮治疗子宫肌瘤比常规治疗安全有效。